Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrent Squamous Cell Lung Carcinoma 2Prostatic Neoplasms 2Colorectal Neoplasms 2Squamous Non-small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solid Malignancies 1Neoplasms 1Lung Cancer Metastatic 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Rare Tumours 1

Interventions

tremelimumab 1durvalumab 1Leucovorin 1Fluorouracil 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Colorectal Cancer Metastatic × tremelimumab × Clear all
NCT03007407 2022-12-05

Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

NSABP Foundation Inc

Phase 2 Completed
33 enrolled 8 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡